Works matching IS 2160763X AND DT 2021 AND VI 10 AND IP 10

Results: 14

Effect of Silymarin Treatment on Circulating Bilirubin and Cardiovascular Disease Risk Factors in Healthy Men: A Single‐Blind, Randomized Crossover Trial.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 10, p. 1156, doi. 10.1002/cpdd.962

By:

Vidimce, Josif;
Pennell, Evan Noel;
Foo, Maxmilian;
Shiels, Ryan Graeme;
Shibeeb, Sapha;
Watson, Michael;
Bulmer, Andrew Cameron

Publication type:

Article

Results of a Dose‐Finding Phase 1b Study of Subcutaneous Atezolizumab in Patients With Locally Advanced or Metastatic Non–Small Cell Lung Cancer.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 10, p. 1142, doi. 10.1002/cpdd.936

By:

Felip, Enriqueta;
Burotto, Mauricio;
Zvirbule, Zanete;
Herraez‐Baranda, Luis A.;
Chanu, Pascal;
Kshirsagar, Smita;
Maiya, Vidya;
Chan, Phyllis;
Pozzi, Emanuela;
Marchand, Mathilde;
Monchalin, Marion;
Tanaka, Kunihiko;
Tosti, Nadia;
Wang, Bei;
Restuccia, Eleonora

Publication type:

Article

Effect of Memantine on QT/QTc Interval in a Healthy Korean Population.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 10, p. 1209, doi. 10.1002/cpdd.931

By:

Park, Jin‐Woo;
Kim, Kyoung‐Ah;
Park, Ji‐Young

Publication type:

Article

Safety, Pharmacokinetics, Pharmacodynamics, and Formulation of Liver‐Distributed Farnesoid X‐Receptor Agonist TERN‐101 in Healthy Volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 10, p. 1198, doi. 10.1002/cpdd.960

By:

Wang, Yujin;
Crittenden, Daria B.;
Eng, Clarence;
Zhang, Qiong;
Guo, Pengfei;
Chung, Diana;
Fenaux, Martijn;
Klucher, Kevin;
Jones, Christopher;
Jin, Feng;
Quirk, Erin;
Charlton, Michael R.

Publication type:

Article

Bioequivalence Study of Oral Suspension and Intravenous Formulation of Edaravone in Healthy Adult Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 10, p. 1188, doi. 10.1002/cpdd.952

By:

Shimizu, Hidetoshi;
Nishimura, Yukiko;
Shiide, Youichi;
Yoshida, Kaori;
Hirai, Manabu;
Matsuda, Munetomo;
Nakamaru, Yoshinobu;
Kato, Yuichiro;
Kondo, Kazuoki

Publication type:

Article

Randomized, Open‐Label, Single‐Dose, Parallel‐Group Pharmacokinetic Study of PF‐06410293 (adalimumab‐afzb), an Adalimumab Biosimilar, by Subcutaneous Dosing Using a Prefilled Syringe or a Prefilled Pen in Healthy Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 10, p. 1166, doi. 10.1002/cpdd.939

By:

Cox, Donna S.;
Alvarez, Daniel F.;
Bock, Amy E.;
Cronenberger, Carol L.

Publication type:

Article

Evaluation of the Potential Effect of Iptakalim Hydrochloride on the QT Interval in Single‐ and Multiple‐Ascending‐Dose Studies Using Concentration‐QTc Analysis.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 10, p. 1231, doi. 10.1002/cpdd.945

By:

Bai, Nan;
Wang, Jin;
Che, Haoyue;
Wang, Hai;
Wang, Rui;
Cai, Yun

Publication type:

Article

Evaluation of Pharmacokinetics, Safety, and Drug‐Drug Interactions of an Oral Suspension of Edaravone in Healthy Adults.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 10, p. 1174, doi. 10.1002/cpdd.925

By:

Shimizu, Hidetoshi;
Nishimura, Yukiko;
Shiide, Yoichi;
Matsuda, Hideaki;
Akimoto, Makoto;
Matsuda, Munetomo;
Nakamaru, Yoshinobu;
Kato, Yuichiro;
Kondo, Kazuoki

Publication type:

Article

Evaluation of the Bioequivalence of Acarbose in Healthy Chinese People.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 10, p. 1225, doi. 10.1002/cpdd.921

By:

Chen, Yan;
Guo, Fahao;
Wang, Xin;
Liu, LuYao;
Yang, Can;
Xiong, YuQing;
Zhang, Hong

Publication type:

Article

Safety of a Novel Weight Loss Combination Product Containing Orlistat and Acarbose.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 10, p. 1242, doi. 10.1002/cpdd.920

By:

Grudén, Stefan;
Forslund, Anders;
Alderborn, Göran;
Söderhäll, Arvid;
Hellström, Per M.;
Holmbäck, Ulf

Publication type:

Article

Pharmacokinetics and Safety of Dapoxetine Hydrochloride in Healthy Chinese Men: Impact of Dose and High‐Fat Meal.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 10, p. 1216, doi. 10.1002/cpdd.919

By:

Liu, Jingyan;
Li, Zhihui;
Yan, Keyu;
Ju, Gehang;
Qiu, Wen

Publication type:

Article

Meta‐analysis of Pharmacokinetic/Pharmacodynamic Results of 3 Phase 1 Studies with Biosimilar Pegfilgrastim.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 10, p. 1130, doi. 10.1002/cpdd.1005

By:

Gattu, Sreekanth;
Wang, Jessie;
Bellon, Anne;
Schelcher, Celine;
Nakov, Roumen;
Arani, Ramin

Publication type:

Article

Issue Information.

Published in:: Clinical Pharmacology in Drug Development, 2021, v. 10, n. 10, p. 1121, doi. 10.1002/cpdd.837
Publication type:: Article

Tirbanibulin: A New Topical Therapy for Actinic Keratoses With a Novel Mechanism of Action and Improved Ease of Use.

Published in:: Clinical Pharmacology in Drug Development, 2021, v. 10, n. 10, p. 1126, doi. 10.1002/cpdd.1024
Publication type:: Article